Hydrazinecarboximidamide, 2-[1-[2-[(2E)-2-[(4-iodophenyl)methylene]hydrazinyl]-4-methyl-5-thiazolyl]ethylidene]- manufacturers
- MMP-2/9-IN-1
-
- $2785.00
-
2026-07-27
- CAS:2415311-84-9
- Purity:
- Supply Ability: 10g
|
| | Hydrazinecarboximidamide, 2-[1-[2-[(2E)-2-[(4-iodophenyl)methylene]hydrazinyl]-4-methyl-5-thiazolyl]ethylidene]- Basic information |
| | Hydrazinecarboximidamide, 2-[1-[2-[(2E)-2-[(4-iodophenyl)methylene]hydrazinyl]-4-methyl-5-thiazolyl]ethylidene]- Chemical Properties |
| Boiling point | 549.8±60.0 °C(Predicted) | | density | 1.77±0.1 g/cm3(Predicted) | | pka | 11.21±0.10(Predicted) |
| | Hydrazinecarboximidamide, 2-[1-[2-[(2E)-2-[(4-iodophenyl)methylene]hydrazinyl]-4-methyl-5-thiazolyl]ethylidene]- Usage And Synthesis |
| Uses | MMP-2/9-IN-1 (Compound 4a) is a potent dual MMP-2 and MMP-9 inhibitor with IC50 values of 56 nM and 38 nM, respectively. MMP-2/9-IN-1 inhibits tumor growth, strongly induces cancer cell apoptosis, inhibits cell migration, and suppresses cell cycle progression leading to DNA fragmentation[1]. | | IC 50 | MMP-9: 38 nM (IC50); MMP-2: 56 nM (IC50) | | References | [1] Omar AM, et al. Novel molecular discovery of promising amidine-based thiazole analogues as potent dual Matrix Metalloproteinase-2 and 9 inhibitors: Anticancer activity data with prominent cell cycle arrest and DNA fragmentation analysis effects. Bioorg Ch DOI:10.1016/j.bioorg.2020.103992 |
| | Hydrazinecarboximidamide, 2-[1-[2-[(2E)-2-[(4-iodophenyl)methylene]hydrazinyl]-4-methyl-5-thiazolyl]ethylidene]- Preparation Products And Raw materials |
|